CVS Health Corporation

NYSE:CVS

57.98 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985
Revenue 356,623321,629292,111268,706256,776194,579184,765177,526153,290139,367126,761123,133107,10096,41398,72987,471.976,329.543,813.837,006.230,594.326,58824,181.522,241.420,087.518,098.315,273.612,738.25,528.19,689.111,285.610,435.410,432.89,886.28,686.87,5546,780.45,930.35,262.44,774.9
Cost of Revenue 303,345267,965240,063219,660211,248163,041156,220148,669126,762114,000102,978100,62786,53976,15678,34969,181.560,221.831,874.827,10522,563.119,72518,112.716,550.414,725.813,236.911,144.49,294.13,920.76,544.17,252.66,664.46,529.26,163.95,372.44,564.14,085.63,567.83,141.12,853.9
Gross Profit 53,27853,66452,04849,04645,52831,53828,54528,85726,52825,36723,78322,50620,56120,25720,38018,290.416,107.711,9399,901.28,031.26,8636,068.85,6915,361.74,861.44,129.23,444.11,607.43,1454,0333,7713,903.63,722.33,314.42,989.92,694.82,362.52,121.31,921
Gross Profit Ratio 0.1490.1670.1780.1830.1770.1620.1540.1630.1730.1820.1880.1830.1920.210.2060.2090.2110.2720.2680.2630.2580.2510.2560.2670.2690.270.270.2910.3250.3570.3610.3740.3770.3820.3960.3970.3980.4030.402
Reseach & Development Expenses 000000000000000000000000000000000000000
General & Administrative Expenses 38,22037,17736,22734,45932,22920,38318,29018,05616,63316,33115,64115,05714,23114,092012,244.208,7647,292.66,0805,0984,5524,2533,7423,4482,9492,575.41,174.12,722.63,2162,956.13,341.72,914.22,535.82,231.22,0231,766.91,573.71,408.9
Selling & Marketing Expenses 985745707613396364230216221212177221000000.10-0.3-0.30.3-5.90.4000000000000000
SG&A 39,20537,92236,93435,07232,62520,74718,52018,27216,85416,54315,81815,27814,23114,092012,244.211,314.48,764.17,292.66,079.75,097.74,552.34,247.13,742.43,4482,9492,575.41,174.12,722.63,2162,956.13,341.72,914.22,535.82,231.22,0231,766.91,573.71,408.9
Other Expenses 1,3958,45737,06635,13533,5414-20818,51917,07416,56815,74615,2780013,9420-0.4732.9589.1497.3341.3309.7678.9296.6278408226.2133.7228.4206.3191.6201138.5114.497.882.27264.163.1
Operating Expenses 40,60046,37937,06635,13533,54121,36819,02818,51917,07416,56815,74615,27814,23114,09213,94212,244.211,314.49,497.47,881.76,576.56,521.34,862.64,567.94,0393,725.93,198.72,801.61,307.82,9513,422.33,147.73,542.73,052.72,650.22,3292,105.21,838.91,637.81,472
Operating Income 14,07315,74213,19313,91111,9874,0219,51710,3389,4548,7998,0377,2286,3306,1656,4386,046.24,793.32,441.62,019.51,454.7341.71,206.2770.61,322.71,135.5930.5642.5299.6194610.7623.3360.9669.6664.2660.9589.6523.6483.5449
Operating Income Ratio 0.0390.0490.0450.0520.0470.0210.0520.0580.0620.0630.0630.0590.0590.0640.0650.0690.0630.0560.0550.0480.0130.050.0350.0660.0630.0610.050.0540.020.0540.060.0350.0680.0760.0870.0870.0880.0920.094
Total Other Income Expenses Net -2,900-9,906-2,773-4,141-2,990-6,145-208-643-838-521-509-348-584-536-525-509.5-434.3-215.6-110.5-58.71,034.3-50.2-352.5-79.7-59.5-158.3-442.7127-936.41.521.3-80-9.7-8.4-4.8-4-3.5-0.7
Income Before Tax 11,1735,83610,4209,7708,9971,4068,2688,6378,6167,6787,5286,3235,7465,6295,9135,536.74,358.72,225.81,9091,396.41,375.51,155.8709.61,243.41,076.4711.3155403.4-797.8526.2552.2281.7589.6587.3606.1542.5476.1432.2391.2
Income Before Tax Ratio 0.0310.0180.0360.0360.0350.0070.0450.0490.0560.0550.0590.0510.0540.0580.060.0630.0570.0510.0520.0460.0520.0480.0320.0620.0590.0470.0120.073-0.0820.0470.0530.0270.060.0680.080.080.080.0820.082
Income Tax Expense 2,8051,5092,5222,5692,3662,0021,6373,3173,3863,0332,9282,4412,2582,1902,2052,192.61,721.7856.9684.3477.6528.2439.2296.4497.4441.3314.9117.7163.8-182.1218.7220.4125.7242.9202208188190.7193.9171.4
Net Income 8,3444,3118,0017,1796,634-5946,6225,3175,2374,6444,5923,8773,4613,4273,6963,212.12,6371,368.91,224.7918.8847.3716.6413.2746635.1396.437.775.4-657.2307.5331.8133.4346.7385.3398.1354.5285.4238.3210.2
Net Income Ratio 0.0230.0130.0270.0270.026-0.0030.0360.030.0340.0330.0360.0310.0320.0360.0370.0370.0350.0310.0330.030.0320.030.0190.0370.0350.0260.0030.014-0.0680.0270.0320.0130.0350.0440.0530.0520.0480.0450.044
EPS 6.493.2965.485.1-0.576.474.934.663.983.773.052.592.512.582.231.971.651.491.131.060.90.510.940.80.480.10.27-1.520.690.60.280.80.90.890.410.660.550.49
EPS Diluted 6.473.265.955.465.08-0.576.444.94.633.963.743.032.572.492.552.181.921.61.451.11.030.880.50.920.780.480.0950.26-1.520.690.60.280.80.90.890.410.660.550.49
EBITDA 18,43919,96619,67618,55816,48212,89211,99613,45611,54610,7459,9079,3297,8987,6347,8277,320.45,887.93,174.92,608.61,951.5683.41,516.51,796.41,619.31,413.41,338.51,311.4306.31,358.8815.5812.9560.6808.1788.3767.1676.6599.6551.1512.8
EBITDA Ratio 0.0520.0620.0670.0690.0640.0660.0650.0760.0750.0770.0780.0760.0740.0790.0790.0840.0770.0720.070.0640.0260.0630.0810.0810.0780.0880.1030.0550.140.0720.0780.0540.0820.0910.1020.10.1010.1050.107